Cited by 337Neuroinflammation and Neurodegeneration MechanismsComplement system in diseasesAlzheimer's disease research and treatments

Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain

Open access
Fonseca, Maria I., Chu, Shu-Hui, Hernandez, Michael X., Fang, Melody J., Modarresi, Lila, Selvan, Pooja, MacGregor, Grant R., Tenner, Andrea J.·2017·Journal of Neuroinflammation

Abstract

The complement cascade not only provides protection from infection but can also mediate destructive inflammation. Complement is also involved in elimination of neuronal synapses which is essential for proper development, but can be detrimental during aging and disease. C1q, required for several of these complement-mediated activities, is present in the neuropil, microglia, and a subset of interneurons in the brain. To identify the source(s) of C1q in the brain, the C1qa gene was selectively inactivated in the microglia or Thy-1+ neurons in both wild type mice and a mouse model of Alzheimer’s disease (AD), and C1q synthesis assessed by immunohistochemistry, QPCR, and western blot analysis. While C1q expression in the brain was unaffected after inactivation of C1qa in Thy-1+ neurons, the brains of C1qa FL/FL :Cx3cr1 CreERT2 mice in which C1qa was ablated in microglia were devoid of C1q with the exception of limited C1q in subsets of interneurons. Surprisingly, this loss of C1q occurred even in the absence of tamoxifen by 1 month of age, demonstrating that Cre activity is tamoxifen-independent in microglia in Cx3cr1 CreERT2/WganJ mice. C1q expression in C1qa FL/FL : Cx3cr1 CreERT2/WganJ mice continued to decline and remained almost completely absent through aging and in AD model mice. No difference in C1q was detected in the liver or kidney from C1qa FL/FL : Cx3cr1 CreERT2/WganJ mice relative to controls, and C1qa FL/FL : Cx3cr1 CreERT2/WganJ mice had minimal, if any, reduction in plasma C1q. Thus, microglia, but not neurons or peripheral sources, are the dominant source of C1q in the brain. While demonstrating that the Cx3cr1 CreERT2/WganJ deleter cannot be used for adult-induced deletion of genes in microglia, the model described here enables further investigation of physiological roles of C1q in the brain and identification of therapeutic targets for the selective control of complement-mediated activities contributing to neurodegenerative disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12974-017-0814-9

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Microglial-expressed complement components including C1q bind to synapses and enable phagocytosis by microglia.

    “microglial-expressed complement components, including C1q, are thought to bind to synapses and enable phagocytosis by microglia [75, 103]”
  • Cx3cr1CreER mouse lines can induce loxP recombination in microglia in the absence of TAM.

    “In certain cases, it has also been shown that Cx3cr1CreER mouse lines can induce loxP recombination in microglia in the absence of TAM.16–18”

    From A comparative analysis of microglial inducible Cre lines (2023) · cites this paper as [16]

  • The iSuReCre allele is recombined by DCXCreER, similar to other Cre and CreER lines tested in the original publication, but is not recombined in adult microglia by P2ry12CreER.

    “These data confirm that the iSuReCre allele is recombined by DCXCreER, similar to other Cre and CreER lines tested in the original publication20, but is not recombined in adult microglia by P2ry12CreER.”

    From A comparative evaluation of the strengths and potential caveats of the microglial inducible CreER mouse models (2024) · cites this paper as [20]

    The Methods (Generation of mouse models; page unavailable) describe testing C1qa floxed mice with Cx3cr1, Thy1, and Rosa26 CreERT2 lines, and the Results report recombination of a separate tdTomato reporter. Our copy does not address iSuReCre recombination by DCXCreER, P2ry12CreER, or the other lines invoked by the comparison (searched: iSuReCre, DCXCreER, P2ry12CreER, reporter-allele recombination). (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • Microglia are the main source of C1q in the brain.

    “they are the main source of C1q in the brain (Fonseca et al., 2017)”

    From Microglia in Alzheimer’s disease (2018) · cites this paper as Fonseca et al., 2017

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fonseca, M. I., Chu, S.-H., Hernandez, M. X., Fang, M. J., Modarresi, L., Selvan, P., MacGregor, G. R., & Tenner, A. J.
Affiliations
University of California, Irvine (US)
Corresponding author
Tenner, Andrea J.
Venue
Journal of Neuroinflammation
Published
2017-03-06
Volume
14
Issue
1
Pages
48-48
ISSN
1742-2094 (ISSN-L)
OpenAlex
W2594676718
Cited by
337
References
63
Citations by year
2026: 26 · 2025: 45 · 2024: 38 · 2023: 53 · 2022: 41 · 2021: 49 · 2020: 30 · 2019: 28 · 2018: 19 · 2017: 8
FWCI
11.59
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroinflammation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
National Institute on Aging (AG 00538, T32 AG000096)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
C1q, complement system, microglia, C1QA, cell-specific gene deletion, Alzheimer's disease, aging, neurodegeneration
MeSH terms
CX3C Chemokine Receptor 1, Animals, Animals, Newborn, beta-Galactosidase, Brain, Gene Expression Regulation, Luminescent Proteins, Mice, Inbred C57BL, Mice, Transgenic, Neurons, RNA, Messenger, Complement C1q, Microglia, Thy-1 Antigens, Neuropil, Receptors, Chemokine, CD11b Antigen, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review